Acute Myeloid Leukemia, Childhood

Search Trials
Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Dec 28, 2017
First Changed:
Jan 11, 2006
Disease(s):
Leukemia
Intervention(s):
aldesleukintherapeutic allogeneic lymphocytescyclophosphamidefludarabine phosphatein vitro treated peripheral blood stem cell transplantation
Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status:
Completed
Last Changed:
Apr 2, 2010
First Changed:
Mar 25, 2004
Disease(s):
Leukemia
Intervention(s):
cyclosporinefludarabine phosphategemtuzumab ozogamicinmethotrexatemycophenolate mofetilallogeneic bone marrow transplantationperipheral blood stem cell transplantationradiation therapy
Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Aug 24, 2010
First Changed:
Oct 7, 2003
Disease(s):
Leukemia
Intervention(s):
cyclophosphamidemethotrexateallogeneic bone marrow transplantationperipheral blood stem cell transplantationiodine I 131 monoclonal antibody BC8radiation therapy
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Mar 15, 2017
First Changed:
May 7, 2007
Disease(s):
Leukemia
Intervention(s):
cytarabineidarubicinlestaurtinib
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
May 12, 2015
First Changed:
Jun 24, 2010
Disease(s):
Leukemia
Intervention(s):
western blottingflow cytometrylaboratory biomarker analysis

Connect. Empower. Inspire.